These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9653322)

  • 21. Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma.
    Rothe A; Schulz H; Elter T; Engert A; Reiser M
    Haematologica; 2004 Jul; 89(7):875-6. PubMed ID: 15257947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
    van der Eijk AA; Doorduijn JK; Janssen HL; Schalm SW; Niesters HG; de Man RA
    Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1140-4. PubMed ID: 12092307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.
    Link BK; Ballas ZK; Weisdorf D; Wooldridge JE; Bossler AD; Shannon M; Rasmussen WL; Krieg AM; Weiner GJ
    J Immunother; 2006; 29(5):558-68. PubMed ID: 16971811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [First antibody in oncology continues on a successful course].
    Papadopoulos DO
    Krankenpfl J; 2004; 42(5-6):162-5. PubMed ID: 15527227
    [No Abstract]   [Full Text] [Related]  

  • 25. [A closer look at a frequently occurring and fundamental problem. Fatigue under chemotherapy (1)].
    Hagemeijer A; Prins K; Courtens A
    TVZ; 1997 Nov; 107(21):634-7. PubMed ID: 9464147
    [No Abstract]   [Full Text] [Related]  

  • 26. A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.
    O'Connor OA; Portlock C; Moskowitz C; Straus D; Hamlin P; Stubblefield M; Dumetrescu O; Colevas AD; Grant B; Zelenetz A
    Br J Haematol; 2008 Oct; 143(2):201-9. PubMed ID: 18691173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inefficacy of rituximab in a case of low grade non-Hodgkin's lymphoma with cryoglobulinemia.
    Baronciani D; Angelucci E; Gaziev J; Visani G
    Haematologica; 2002 Jul; 87(7):ELT33. PubMed ID: 12091148
    [No Abstract]   [Full Text] [Related]  

  • 28. Outpatient clinic uses ambulatory infusion devices.
    Blendowski C
    Oncol Nurs Forum; 1994 Aug; 21(7):1250. PubMed ID: 7971438
    [No Abstract]   [Full Text] [Related]  

  • 29. Ambulatory chemotherapy.
    Seymour MT; Slevin ML
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):1-3. PubMed ID: 1736972
    [No Abstract]   [Full Text] [Related]  

  • 30. Rituximab: a new monoclonal antibody therapy for non-Hodgkin's lymphoma.
    Kosits C; Callaghan M
    Oncol Nurs Forum; 2000; 27(1):51-9. PubMed ID: 10660923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of high-dose chemotherapy with hematopoietic stem cell transplantation for malignant lymphoma].
    Okamoto M
    Rinsho Ketsueki; 2001 Apr; 42(4):299-306. PubMed ID: 11400301
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ambulatory management of patients with external insulin pumps].
    Toury I; Hurault C
    Soins; 2002 Sep; (668):23-4. PubMed ID: 12271773
    [No Abstract]   [Full Text] [Related]  

  • 33. [Our outpatient cases for home anti-cancer chemotherapy using a CV port and a portable pump system].
    Midorikawa Y; Nakachi T; Kasuga T
    Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():264-6. PubMed ID: 17469355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trial of the monoclonal antibody drug mabthera (Rituximab) in the treatment of non-Hodgkin lymphoma].
    Korolenko VO; Gershanovich ML; Leenman EE; Tikhonova VV
    Vopr Onkol; 2003; 49(4):459-63. PubMed ID: 14569937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose sodium selenite can induce apoptosis of lymphoma cells in adult patients with non-Hodgkin's lymphoma.
    Asfour IA; El-Tehewi MM; Ahmed MH; Abdel-Sattar MA; Moustafa NN; Hegab HM; Fathey OM
    Biol Trace Elem Res; 2009 Mar; 127(3):200-10. PubMed ID: 18953506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?
    Rodriguez J
    Nat Clin Pract Oncol; 2005 Feb; 2(2):74-5. PubMed ID: 16264876
    [No Abstract]   [Full Text] [Related]  

  • 37. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma.
    Gajra A; Vajpayee N; Grethlein SJ
    Am J Hematol; 2004 Oct; 77(2):196-7. PubMed ID: 15389902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ambulatory antineoplastic chemotherapy maintenance: advantages and disadvantages].
    Fossati C
    Clin Ter; 1978 Mar; 84(6):637-40. PubMed ID: 648109
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of electronic pagers to recall patients undergoing outpatient-based chemotherapy.
    Farrugia D; Ingledew I; Dawes E; Moss S
    Eur J Oncol Nurs; 2006 Apr; 10(2):156-60. PubMed ID: 16434231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of low grade and intermediate grade non-Hodgkin's lymphomas with intensive combination chemotherapy.
    Bolaman Z; Sentürk T; Kadköylü G
    Haematologica; 1999; 84(E-letters):E03. PubMed ID: 11084661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.